ID: ALA4776260

Max Phase: Preclinical

Molecular Formula: C39H59N5O6S

Molecular Weight: 726.00

Molecule Type: Unknown

Representations

Canonical SMILES:  CCO[C@H](C[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H]1[C@@H]2CC[C@@H](C2)N1C)[C@@H](C)CC)c1nc(C(=O)N[C@@H](Cc2ccccc2)C[C@H](C)C(=O)O)cs1

Standard InChI:  InChI=1S/C39H59N5O6S/c1-9-24(5)33(42-36(46)34-27-16-17-29(20-27)43(34)7)38(47)44(8)31(23(3)4)21-32(50-10-2)37-41-30(22-51-37)35(45)40-28(18-25(6)39(48)49)19-26-14-12-11-13-15-26/h11-15,22-25,27-29,31-34H,9-10,16-21H2,1-8H3,(H,40,45)(H,42,46)(H,48,49)/t24-,25-,27+,28+,29-,31+,32+,33-,34+/m0/s1

Standard InChI Key:  CBLSCHWOUOWXIH-ABVXVFTMSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 726.00

Molecular Weight (Monoisotopic): 725.4186

AlogP: 5.56

#Rotatable Bonds: 19

Polar Surface Area: 141.17

Molecular Species: ACID

HBA: 8

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 11

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 4.21

CX Basic pKa: 7.45

CX LogP: 2.86

CX LogD: 2.64

Aromatic Rings: 2

Heavy Atoms: 51

QED Weighted: 0.17

Np Likeness Score: 0.07

References

1. Courter JR,Hamilton JZ,Hendrick NR,Zaval M,Waight AB,Lyon RP,Senter PD,Jeffrey SC,Burke PJ.  (2020)  Structure-activity relationships of tubulysin analogues.,  30  (14): [PMID:32527543] [10.1016/j.bmcl.2020.127241]

Source

Source(1):

• Scientific Literature